Brief: Anika Announces FDA 510(K) Clearance For Its Wristmotion Total Arthroplasty System
Oct 21 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA ANNOUNCES FDA 510(K) CLEARANCE FOR ITS WRISTMOTION®
TOTAL
ARTHROPLASTY SYSTEM FOR THE REPLACEMENT OF PAINFUL WRIST JOINTS
Source text for Eikon: ID:nGNXB73r
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%